气泡状免疫分析识别了急性呼吸系统衰竭的不同亚现象
medRxiv : the preprint server for health sciences
|February 6, 2026
概括
研究人员使用肺液生物标志物确定了四种不同的急性呼吸衰竭亚现型. 这些亚表型显示出不同的免疫细胞概况和死亡率,为ARF治疗准确医学铺平了道路.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 急性呼吸衰竭 (ARF) 是全球主要的死亡原因.
- 目前的ARF亚型依赖于外周血液,但肺部特定的个人资料仍未被探索.
- 了解ARF病理生理学对于识别治疗反应良好的患者群体至关重要.
研究的目的:
- 用肺特异性分子形状来定义具有生物学和临床意义的ARF亚表型.
- 调查这些亚表型与患者死亡率之间的关联.
- 探索不同ARF亚型的免疫细胞特征.
主要方法:
- 从466名ARF患者的膜液中分析了25种可溶性蛋白质.
- 在48名参与者中使用光谱流细胞计进行免疫类型鉴定.
- 开发和验证一个分类器来预测子类型.
主要成果:
- 确定了四种不同的ARF亚型,其28天死亡率有所不同 (12.7%至29.4%).
- 亚表型在可溶性蛋白质水平,免疫细胞种群 (例如T细胞) 和炎症媒介方面有所不同.
- 一个分类器成功地预测了独立队列中的子类型,尽管死亡率相关性并未始终被检测到.
结论:
- 已经确定了具有独特免疫特征和临床结果的新型ARF亚型.
- 肺部特异性的分子测量对于定义ARF亚表型非常有价值.
- 这些发现支持将精准医学方法纳入ARF管理.
更多相关视频
16:56Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
17.6K
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
3.2K
相关概念视频
Acute Respiratory Failure-I
1.0K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.0K
Acute Respiratory Failure-II
1.1K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.1K
Acute Respiratory Failure-V
507
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
507
Acute Respiratory Failure-III
914
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
914
Acute Respiratory Failure-IV
575
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
575
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
628
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
628
